ABSTRACT
Objective Single voxel proton spectroscopy technique (1H-MRS)was performed in the healthy newborn brain tissue to investigate the metabolic ratio in the right basal ganglia and the right frontal lobe changes with gestational age, and to improve the understanding of the neonatal brain development. Methods In this study, 69 newborns were selected, including twenty-five premature and forty-four term neonates. By using the Gesell developmental scale to evaluate brain development , they all had normal neurologic outcomes at 12-months corrected age. A point-resolved spectroscopy sequence was used to study the metabolic data obtained from each region of interest. Results N-acetylaspartate: creatine and N-acetylaspartate:choline were positively correlated with gestational age (the right basal ganglia r = 0.27, 0.63, the right frontal lobe r = 0.44, 0.64 respectively, P < 0.05) and choline:creatine was negative (the right basal ganglia r = -0.51,the right frontal lobe r = -0.41, P < 0.05), with a linear regression relationship among variables. In the same gestational age group , the N-acetylaspartate: choline of the right basal ganglia was higher than that of the right frontal lobe , and the metabolic ratios among the anatomic locations were significantly different (P < 0.05). Conclusion Neonatal brain metabolite levels are associated with gestational age , and MRS can monitor newborn brain maturation quantitatively.
ABSTRACT
<p><b>OBJECTIVE</b>To explore the relationship between the relevant factors and prostate cancer among Hui and Han populations.</p><p><b>METHODS</b>The study involved 267 prostate cancer patients as cases (214 cases from Han population and 53 cases from Hui population) and 534 prostatic hyperplasia patients as controls (428 cases from Han population and 106 cases from Hui population). All the patients were collected from the General Hospital of Ningxia Medical University during January of 2007 to September of 2013. The level of fasting blood glucose (FBG), total cholesterol (TC), triglyceride (TG), total prostate specific antigen (T-PSA), free prostate specific antigen (F-PSA) and free/total prostate specific antigen (F/T-PSA) were collected from the clinical medical records of the patients. Data were analyzed by the conditional logistic regression method, and attributable risk proportion(ARP) was calculated.</p><p><b>RESULTS</b>In Hui population, the risk of prostate cancer for drinkers was 20.48 times higher than the non-drinkers (35.8% (19/53) to 5.7% (6/106), OR = 20.48, 95% CI: 4.95-84.66). The high level of F-PSA significantly increased the risk of prostate cancer for Hui group (83.0% (44/53) to 55.7% (59/106), OR = 4.27, 95%CI: 1.18-15.43). In contrast, the high TG level decreased the risk of prostate cancer for Hui group (18.9% (10/53) to 20.8% (22/106), OR = 0.24, 95% CI: 0.07-0.83). In Han population, the risk of prostate cancer for smokers was 1.89 times higher than the non-smokers (55.1% (118/214) to 39.7% (170/428), OR = 1.89, 95% CI: 1.28-2.78). Either high level of T-PSA or F-PSA increased the risk of prostate cancer for Han group (86.4% (185/214) to 53.7% (230/428),OR = 2.34, 95%CI:1.22-4.52;85.5% (183/214) to 56.1% (240/428), OR = 2.43, 95% CI:1.29-4.59). However, the high TG level or high ratio of F/T-PSA decreased the risk of prostate cancer (15.4% (33/214) to 18.7% (80/428), OR = 0.59, 95% CI:0.36-0.98; 53.3% (114/214) to 73.4% (314/428), OR = 0.53, 95% CI:0.36-0.78). The APRs of drinking and high level of F-PSA in Han populations were 66.6%, 62.4% in Hui populations , and the APRs of smoking and high level of T-PSA, high level of F-PSA were 33.8%, 71.3%, 67.3% in Han populations.</p><p><b>CONCLUSION</b>Both drinking and high level of F-PSA might be the risky factors of prostate cancer while the high TG level might be protective factor for Hui group. However, for Han population, smoking, high T-PSA level, and high F-PSA level might be risky factors for prostate cancer while the high TG level and high ratio of F/T-PSA might be protective factors. In summary, the clinical relevant factors of prostate cancer may play different roles between Hui and Han populations in Ningxia region.</p>